Amplia Therapeutics Ltd.ASX: ATX

FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis

May 19, 2020 at 8:53 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment